Improving adherence to secondary stroke prevention strategies through motivational interviewing: Randomized controlled trial

Stroke

Volumn 46, Issue 12, 2015, Pages 3451-3458

  Barker Collo, Suzanne ^a   Krishnamurthi, Rita ^b   Witt, Emma ^b   Feigin, Valery ^b   Jones, Amy ^b   Mcpherson, Kathryn ^c   Starkey, Nicola ^d   Parag, Varsha ^a   Jiang, Yannan ^a   Barber, P Alan ^a   Rush, Elaine ^b   Bennett, Derrick ^e   Aroll, Bruce ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

^c Chief Executive Health Research Council of New Zealand   (New Zealand)

^d UNIVERSITY OF WAIKATO   (New Zealand)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

blood pressure; motivational interviewing; randomized controlled trial; secondary prevention; stroke

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MEDICATION COMPLIANCE; MOTIVATIONAL INTERVIEWING; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE; CLINICAL TRIAL; FEMALE; MALE; PROCEDURES; PSYCHOLOGY; RISK REDUCTION; SECONDARY PREVENTION; STROKE;

ADULT; FEMALE; HUMANS; MALE; MOTIVATIONAL INTERVIEWING; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; RISK REDUCTION BEHAVIOR; SECONDARY PREVENTION; SINGLE-BLIND METHOD; STROKE;

EID: 84948085537     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.011003     Document Type: Article

References (52)

1. Talelli P, Greenwood RJ., Recurrent stroke: where do we stand with the secondary prevention of noncardioembolic ischaemic strokes? Ther Adv Cardiovasc Dis 2008 2 387 405. doi: 10.1177/1753944708093411.
2. Hankey GJ., Secondary prevention of recurrent stroke. Stroke 2005 36 218 221. doi: 10.1161/01.STR.0000153048.87248.3b.
3. Diener HC, Weimar C., Update of secondary stroke prevention. Nephrol Dial Transplant 2009 24 1718 1724. doi: 10.1093/ndt/gfp068.
4. Anderson CS, Carter KN, Hackett ML, Feigin V, Barber PA, Broad JB, Auckland Regional Community Stroke (ARCOS) Study Group Trends in stroke incidence in Auckland, New Zealand, during 1981 to 2003. Stroke 2005 36 2087 2093. doi: 10.1161/01.STR.0000181079.42690.bf.
5. Boysen G, Truelsen T., Prevention of recurrent stroke. Neurol Sci 2000 21 67 72
6. Hardie K, Hankey GJ, Jamrozik K, Broadhurst RJ, Anderson C., Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study. Stroke 2004 35 731 735. doi: 10.1161/01.STR.0000116183.50167.D9.
7. Phillips RA., A review of therapeutic strategies for risk reduction of recurrent stroke. Prog Cardiovasc Dis 2008 50 264 273. doi: 10.1016/j.pcad.2007.09.001.
8. Micieli G, Cavallini A, Quaglini S, Guideline Application for Decision Making in Ischemic Stroke (GLADIS) Study Group Guideline compliance improves stroke outcome: a preliminary study in 4 districts in the Italian region of Lombardia. Stroke 2002 33 1341 1347
9. Graham GD., Secondary stroke prevention: from guidelines to clinical practice. J Natl Med Assoc 2008 100 1125 1137
10. Gall SL, Dewey HM, Thrift AG., Smoking cessation at 5 years after stroke in the North East Melbourne stroke incidence study. Neuroepidemiology 2009 32 196 200. doi: 10.1159/000195689.
11. Holloway RG, Benesch C, Rush SR., Stroke prevention: narrowing the evidence-practice gap. Neurology 2000 54 1899 1906
12. Polk DM, Watson K., Hospital discharge treatments after an acute event: evidence for a systems approach to prevention. Coron Artery Dis 2006 17 239 241
13. Bushnell CD, Colón-Emeric CS., Secondary stroke prevention strategies for the oldest patients: possibilities and challenges. Drugs Aging 2009 26 209 230
14. Quilliam BJ, Lapane KL., Clinical correlates and drug treatment of residents with stroke in long-Derm care. Stroke 2001 32 1385 1393
15. Channon S, Smith VJ, Gregory JW., A pilot study of motivational interviewing in adolescents with diabetes. Arch Dis Child 2003 88 680 683
16. Brodie DA, Inoue A, Shaw DG., Motivational interviewing to change quality of life for people with chronic heart failure: a randomised controlled trial. Int J Nurs Stud 2008 45 489 500. doi: 10.1016/j.ijnurstu.2006.11.009.
17. Cummings SM, Cooper RL, Cassie KM., Motivational interviewing to affect behavioral change in older adults. Res Social Work Prac 2009 19 195 204
18. Aspegren K, Risager NE, Strømning M., [Learning "The Motivational Interview" in a simple way]. Ugeskr Laeger 2008 170 39 43
19. Castro MMLD, Passos SRL., Motivational interview and scales used to assess the degree of motivation for treatment in drug abuse patients. Revista de Psiquiatria Clínica 2005 32 330 335
20. Florez-Alarcon L, Carranza WA., The motivational interview as a tool for encouraging lifestyle changes in people with chronic non transmittable diseases. Avances en Psicología Latinoamericana 2007 25 63 82
21. Lussier MT, Richard C., The motivational interview: in practice. Can Fam Physician 2007 53 2117 2118
22. Miller RW, Rollnick S., Motivational Interviewing: Preparing People to Change Addctive Behavior 1991 New York, NY The Guilford Press
23. Rollnick S, Mason P, Butler C., Health Behavior Change: A Guide for Practitioners 2000 New York, NY Churchill Livingstone
24. Dunn C, Deroo L, Rivara FP., The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review. Addiction 2001 96 1725 1742. doi: 10.1080/09652140120089481.
25. Heather N., Comments on Dunn et al.'s "The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review". Motivational interviewing: effectiveness and cost-effectiveness. Addiction 2001 96 1772 1773, discussion 1774
26. Groeneveld IF, Proper KI, van der Beek AJ, van Duivenbooden C, van Mechelen W., Design of a RCT evaluating the (cost-) effectiveness of a lifestyle intervention for male construction workers at risk for cardiovascular disease: the health under construction study. BMC Public Health 2008 8 1. doi: 10.1186/1471-2458-8-1.
27. Murphy JG, Benson TA, Vuchinich RE, Deskins MM, Eakin D, Flood AM, A comparison of personalized feedback for college student drinkers delivered with and without a motivational interview. J Stud Alcohol 2004 65 200 203
28. Rivera Mercado S, Villouta Cassinelli MF, Ilabaca Grez A., [Motivational interviews: what are their effectiveness in prevalent primary care problems?]. Aten Primaria 2008 40 257 261
29. Watkins CL, Auton MF, Deans CF, Dickinson HA, Jack CI, Lightbody CE, Motivational interviewing early after acute stroke: a randomized, controlled trial. Stroke 2007 38 1004 1009. doi: 10.1161/01.STR.0000258114.28006.d7.
30. Leathley MJ, Fall S, Sharma AK, Watkins C, Barer D., Life after stroke: multi-centre trial of psychosocial interventions after stroke. Cerebrovasc Dis 2003 16 suppl 4 70
31. Lincoln NB, Flannaghan T., Cognitive behavioral psychotherapy for depression following stroke: a randomized controlled trial. Stroke 2003 34 111 115
32. Dennis M, O'Rourke S, Slattery J, Staniforth T, Warlow C., Evaluation of a stroke family care worker: results of a randomised controlled trial. BMJ 1997 314 1071 6; discussion 1076
33. Forster A, Young J., Specialist nurse support for patients with stroke in the community: a randomised controlled trial. BMJ 1996 312 1642 1646
34. Bombardier CH, Bell KR, Temkin NR, Fann JR, Hoffman J, Dikmen S., The efficacy of a scheduled telephone intervention for ameliorating depressive symptoms during the first year after traumatic brain injury. J Head Trauma Rehabil 2009 24 230 238. doi: 10.1097/HTR.0b013e3181ad65f0.
35. Woollard J, Beilin L, Lord T, Puddey I, MacAdam D, Rouse I., A controlled trial of nurse counselling on lifestyle change for hypertensives treated in general practice: preliminary results. Clin Exp Pharmacol Physiol 1995 22 466 468
36. Reid CM, Murphy B, Murphy M, Maher T, Ruth D, Jennings G., Prescribing medication versus promoting behavioural change: a trial of the use of lifestyle management to replace drug treatment of hypertension in general practice. Behaviour Change 1994 11 177 185
37. West DS, DiLillo V, Bursac Z, Gore SA, Greene PG., Motivational interviewing improves weight loss in women with type 2 diabetes. Diabetes Care 2007 30 1081 1087. doi: 10.2337/dc06-1966.
38. Krishnamurthi R, Witt E, Barker-Collo S, McPherson K, Davis-Martin K, Bennett D, ARCOS IV Programme Group Reducing recurrent stroke: methodology of the motivational interviewing in stroke (MIST) randomized clinical trial. Int J Stroke 2014 9 133 139. doi: 10.1111/ijs.12107.
39. Stroke Foundation of New Zealand and New Zealand Guidelines Group (2010) New Zealand Clinical Guidelines for Stroke Management 2010 Wellington, New Zealand Stroke Foundation of New Zealand
40. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V., Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009 8 355 369. doi: 10.1016/S1474-4422(09)70025-0.
41. McDowell I., Measuring Health-A Guide to Rating Scales and Questionnaires 1996 2nd ed New York Oxford University Press
42. Ware JE, Kosinski M, Keller SD., Sf-36 Physical and Mental Health Summary Scales: A Users Manual 1994 Boston, MA The Health Institute, New England Medical Centre
43. Zigmond AS, Snaith RP., The hospital anxiety and depression scale. Acta Psychiatr Scand 1983 67 361 370
44. Scott KM, Tobias MI, Sarfati D, Haslett SJ., SF-36 health survey reliability, validity and norms for New Zealand. Aust N Z J Public Health 1999 23 401 406
45. Bjelland I, Dahl AA, Haug TT, Neckelmann D., The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002 52 69 77
46. Brown DL., ICH e9 guideline " statistical principles for clinical trials': a case study. Stat Med 2002 22 13 15
47. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Consolidated Standards of Reporting Trials Group CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 2010 63 e1 37. doi: 10.1016/j.jclinepi.2010.03.004.
48. Watkins CL, Wathan JV, Leathley MJ, Auton MF, Deans CF, Dickinson HA, The 12-month effects of early motivational interviewing after acute stroke: a randomized controlled trial. Stroke 2011 42 1956 1961. doi: 10.1161/STROKEAHA.110.602227.
49. Hawkshead J, Krousel-Wood MA., Techniques for measuring medication adherence in hypertensive patients in outpatient settings: advantages and limitations. Disabil Manag Health Outcomes 2007 15 109 118
50. Gagné CGG., Improving self-report measures of non-Adherence to HIV medications. Psychol Health 2005 20 803 816
51. Turner BJ., Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients. J Infect Dis 2002 185 Suppl 2 S143 S151. doi: 10.1086/340197.
52. Paterson DL, Potoski B, Capitano B., Measurement of adherence to antiretroviral medications. J Acquir Immune Defic Syndr 2002 31 Suppl 3 S103 S106